{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:36:46Z","timestamp":1788687406355,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.intimp.2021.107972","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T13:02:02Z","timestamp":1626786122000},"page":"107972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The effect of FTY720 at different doses and time-points on LPS-induced acute lung injury in rats"],"prefix":"10.1016","volume":"99","author":[{"given":"Zu-An","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xiu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Ping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2021.107972_b0005","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI60331","article-title":"The acute respiratory distress syndrome","volume":"122","author":"Matthay","year":"2012","journal-title":"J Clin. Invest."},{"issue":"7","key":"10.1016\/j.intimp.2021.107972_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment","volume":"319","author":"Fan","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.intimp.2021.107972_b0015","first-page":"252","article-title":"Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment","volume":"107","author":"Matuschak","year":"2010","journal-title":"Mo Med"},{"issue":"4","key":"10.1016\/j.intimp.2021.107972_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2006-948288","article-title":"Pathophysiology of Acute Lung Injury and the Acute Respiratory Distress Syndrome","volume":"27","author":"Ware","year":"2006","journal-title":"Seminars Respirat. Critical Care Med."},{"key":"10.1016\/j.intimp.2021.107972_b0025","doi-asserted-by":"crossref","unstructured":"Bellani, G ; Laffey, JG ; Pham, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA.2016 Feb 23 ;315(8) :788-800.","DOI":"10.1001\/jama.2016.0291"},{"issue":"11","key":"10.1016\/j.intimp.2021.107972_b0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.201201-0003OC","article-title":"Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury","volume":"185","author":"Dolinay","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.107972_b0035","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.18632\/aging.102804","article-title":"The IL1\u03b2-HER2-CLDN18\/CLDN4 axis mediates lung barrier damage in ARDS","volume":"12","author":"Ma","year":"2020","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.intimp.2021.107972_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2492\/inflammregen.31.167","article-title":"Fingolimod (FTY720), the Sphingosine 1-Phosphate Receptor Modulator, as a New Therapeutic Drug in Multiple Sclerosis","volume":"31","author":"Chiba","year":"2011","journal-title":"Inflamm. Regenerat."},{"issue":"7","key":"10.1016\/j.intimp.2021.107972_b0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/biomedicines8070227","article-title":"Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article","volume":"8","author":"Cohan","year":"2020","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.intimp.2021.107972_b0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/intimm\/dxz037","article-title":"Sphingosine 1-phosphate and inflammation","volume":"31","author":"Obinata","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2021.107972_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","article-title":"The sphingosine 1-phosphate receptor modulator fngolimod as a therapeutic agent: recent fndings and new perspectives","volume":"185","author":"Huwiler","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2021.107972_b0060","first-page":"2600","article-title":"The immunosuppressant fingolimod ameliorates experimental autoimmune myasthenia gravis by regulating T-cell balance and cytokine secretion","volume":"12","author":"Luo","year":"2020","journal-title":"Am. J. Translational Res."},{"issue":"3","key":"10.1016\/j.intimp.2021.107972_b0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1051\/medsci\/2020026","article-title":"Multiple sclerosis and immuno-modulators of sphingosine 1-phosphate receptors","volume":"36","author":"Talmont","year":"2020","journal-title":"Med. Sci. (Paris)"},{"issue":"5","key":"10.1016\/j.intimp.2021.107972_b0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/WCO.0000000000000595","article-title":"Management of chronic inflammatory demyelinating polyradiculopathy","volume":"31","author":"Doneddu","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.intimp.2021.107972_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.intimp.2019.03.017","article-title":"LncRNA analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models","volume":"71","author":"Zhang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2021.107972_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.intimp.2018.06.036","article-title":"Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models","volume":"63","author":"Huang","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.107972_b0085","first-page":"414","article-title":"Establishment of mouse model of acute lung injury with exposed and non-exposed intratracheal instillations and effectiveness comparison","volume":"38","author":"Yu-dan","year":"2012","journal-title":"J. Jilin. Uni(Med Edition)"},{"issue":"2","key":"10.1016\/j.intimp.2021.107972_b0090","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.intimp.2015.10.010","article-title":"Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction","volume":"29","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2021.107972_b0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/ers.10.71","article-title":"The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine","volume":"4","author":"Chen","year":"2010","journal-title":"Expert Rev. Respir. Med."},{"issue":"6","key":"10.1016\/j.intimp.2021.107972_b0100","first-page":"654","article-title":"Sphingosine 1-phosphate signaling pathway: a novel target for regulation of epithelial and endotheli","volume":"47","author":"Huifang","year":"2016","journal-title":"J. China Pharm. Uni."},{"issue":"377","key":"10.1016\/j.intimp.2021.107972_b0105","first-page":"385","article-title":"The sphingosine-1 phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice","volume":"24","author":"M\u00fcller","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2021.107972_b0110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1165\/rcmb.2010-0422OC","article-title":"Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression","volume":"45","author":"Zhao","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2021.107972_b0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms19020588","article-title":"New Insights into the Immune Molecular Regulation of the Pathogenesis of Acute Respiratory Distress Syndrome","volume":"19","author":"Chin-Yao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2021.107972_b0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.intimp.2021.107972_b0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17476348.2018.1548280","article-title":"The acute respiratory distress syndrome: pathophysiology, current clinical practice, and emerging therapies","volume":"12","author":"Derwall","year":"2018","journal-title":"Expert. Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.intimp.2021.107972_b0130","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.immuni.2015.03.007","article-title":"Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1\u03b1 Release","volume":"42","author":"Dagvadorj","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2021.107972_b0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2021.107972_b0140","first-page":"343","article-title":"NF-\u03baB and Its Regulation on the Immune System","volume":"1","author":"Liang","year":"2004","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.107972_b0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-\u03baB and the Transcriptional Control of Inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2021.107972_b0150","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/13880209.2019.1648523","article-title":"The regulatory effect of flavonoids extracted from Abutilon theophrasti leaves on gene expression in LPS-induced ALI mice via the NF-\u03baB and MAPK signaling pathways","volume":"57","author":"Tian","year":"2019","journal-title":"Pharm. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2021.107972_b0155","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.4049\/jimmunol.176.8.4995","article-title":"Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury","volume":"176","author":"Everhart","year":"2006","journal-title":"J. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921006081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:13:54Z","timestamp":1730837634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921006081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":31,"alternative-id":["S1567576921006081"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107972","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of FTY720 at different doses and time-points on LPS-induced acute lung injury in rats","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.107972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107972"}}